Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

Efficacy and Safety of RC48-ADC, a Her2-Targeting Antibody-Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: A Phase 2, Open-Label, Multi-Centre, Single-Arm Study

SSRN Electronic Journal ◽

10.2139/ssrn.3460675 ◽

2019 ◽

Author(s):

Xinan Sheng ◽

Xieqiao Yan ◽

Lin Wang ◽

Yanxia Shi ◽

Xin Yao ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Efficacy And Safety ◽

Antibody Drug Conjugate ◽

Open Label ◽

Drug Conjugate ◽

Metastatic Urothelial Carcinoma ◽

Antibody Drug

Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma who have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicenter, Phase 2 Trial

European Urology ◽

10.1016/j.eururo.2016.10.012 ◽

2017 ◽

Vol 71 (2) ◽

pp. 299-300

Author(s):

Bernard H. Bochner

Keyword(s):

Urothelial Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00438-6 ◽

2016 ◽

Vol 17 (1) ◽

pp. 48-56 ◽

Cited By ~ 108

Author(s):

Michael L Wang ◽

Hun Lee ◽

Hubert Chuang ◽

Nicolaus Wagner-Bartak ◽

Frederick Hagemeister ◽

...

Keyword(s):

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Phase 2 Trial ◽

Mantle Cell ◽

Open Label Phase

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

The Lancet ◽

10.1016/s0140-6736(16)00561-4 ◽

2016 ◽

Vol 387 (10031) ◽

pp. 1909-1920 ◽

Cited By ~ 1743

Author(s):

Jonathan E Rosenberg ◽

Jean Hoffman-Censits ◽

Tom Powles ◽

Michiel S van der Heijden ◽

Arjun V Balar ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Faculty Opinions recommendation of Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726204768.793531746 ◽

2017 ◽

Author(s):

John Nemunaitis ◽

Luisa Manning

Keyword(s):

Urothelial Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Phase 2 study of pembrolizumab alone or combined with acalabrutinib in platinum-refractory metastatic urothelial carcinoma (mUC)

Annals of Oncology ◽

10.1093/annonc/mdx371.017 ◽

2017 ◽

Vol 28 ◽

pp. v303-v304 ◽

Cited By ~ 2

Author(s):

T. Zhang ◽

M. Harrison ◽

P. O'Donnell ◽

A. Alva ◽

N. Hahn ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase 2 ◽

Phase 2 Study ◽

Platinum Refractory ◽

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(18)30015-9 ◽

2018 ◽

Vol 19 (2) ◽

pp. 181-193 ◽

Cited By ~ 118

Author(s):

Rodabe N Amaria ◽

Peter A Prieto ◽

Michael T Tetzlaff ◽

Alexandre Reuben ◽

Miles C Andrews ◽

...

Keyword(s):

High Risk ◽

Standard Of Care ◽

Phase 2 ◽

Single Centre ◽

Open Label ◽

Phase 2 Trial

Pembrolizumab and nanoparticle albumin bound paclitaxel (nab-paclitaxel) for metastatic urothelial carcinoma (UC) after chemotherapy failure: the open-label, single-arm, phase 2 PEANUT study

Annals of Oncology ◽

10.1093/annonc/mdx371.072 ◽

2017 ◽

Vol 28 ◽

pp. v325-v326

Author(s):

A. Necchi ◽

L. Mariani ◽

A. Anichini ◽

P. Giannatempo ◽

D. Raggi ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase 2 ◽

Open Label ◽

Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 Trial

The Journal of Urology ◽

10.1016/j.juro.2016.09.025 ◽

2016 ◽

Vol 196 (6) ◽

pp. 1637-1638 ◽

Cited By ~ 1

Author(s):

Sam S. Chang

Keyword(s):

Urothelial Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Multicentre Phase ◽

Phase 2 Trial ◽

Multicenter Randomized Phase 2 Trial of Gemcitabine – Platinum with or without Trastuzumab (T) in Advanced / Metastatic Urothelial Carcinoma (A/MUC) with HER2 Overexpression

Annals of Oncology ◽

10.1016/s0923-7534(20)33381-0 ◽

2012 ◽

Vol 23 ◽

pp. ix259 ◽

Cited By ~ 2

Author(s):

S. Oudard ◽

S. Culine ◽

A. Vieillefond ◽

F. Priou ◽

F. Goldwasser ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Her2 Overexpression ◽

Phase 2 ◽

Phase 2 Trial ◽

Metastatic Urothelial Carcinoma ◽

Randomized Phase 2